DOCSLIB.ORG

Maryland Healthchoice ER Auto-Pay List Effective November 1, 2012

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Maryland Healthchoice ER Auto-Pay List Effective November 1, 2012 Maryland HealthChoice ER Auto-Pay List Effective November 1, 2012 Diagnosis DESCRIPTION 033.9Cd Whooping cough; unspecified organism 040.82 Toxic shock syndrome 053.21 Herpes zoster keratoconjunctivitis 101 Vincent's angina 250.10 Diabetes with ketoacidosis; type II 250.11 Diabetes with ketoacidosis; type I 250.12 Diabetes with ketoacidosis, type II 250.13 Diabetes with ketoacidosis, type I 250.30 Diabetes with other coma, type II 250.32 Diabetes with other coma, type II 251.0 Hypoglycemic coma 251.1 Other specified hypoglycemia 251.2 Hypoglycemia, unspecified 276.5 Volume depletion 276.50 Volume depletion; unspecified 276.51 Dehydration 276.52 Hypovolemia 276.7 Hyperpotassemia 276.8 Hypopotassemia 282.42 Sickle-Cell Thalassemia w/Crisis 282.62 Hb-S disease with mention of crisis 282.64 Sickle-cell/Hb-C disease with crisis 282.69 Other sickle-cell disease (HbS with D or E) with crisis 288.0 Neutropenia 303.00 Acute alcoholic intoxication; unspec 303.01 Acute alcoholic intoxication, conti 345.10 Generalized convulsive epilepsy 345.11 Generalized convulsive epilepsy 345.3 Epileptic grand mal status 345.90 Unspecified epilepsy without mention of intractable epilepsy 351.0 Bell’s palsy 376.01 Orbital cellulitis 410.41 Acute myocardial infarction 410.71 Acute myocardial infarction 410.90 Acute myocardial infarction, unspecified site, unspecified episode of care 410.91 Acute myocardial infarction; unspecified site; initial episode of care 411.1 Intermediate coronary syndrome 415.19 Other pulmonary embolism and infarc 427.0 Paroxysmal supraventricular tachycaradia 427.41 Ventricular fibrillation 427.5 Cardiac arrest 427.89 Other specified cardiac dysrhythmias 430 Subarachnoid hemorrhage 431 Intracerebral hemorrhage 432.1 Subdural hemorrhage 434.91 Unspecified cerebral artery occlusi 435.9 Unspecified transient cerebral isch 444.9 Arterial Embolism and thrombosis of unspecifed artery 451.0 Phlebitis and thrombophlebitis of superfical vessels of LE 451.19 Phlebitis and thrombophlebitis of deep vessels of LE _ Other 451.2 Phlebitis and thrombophlebitis of LE, unspecified 451.82 Phlebitis and thrombophlebitis of superfical veins of UE 451.9 Phlebitis and thrombophlebitis of unspecified site 453.40 Venous Embolism And Thrombosis Of unspecified deep vessels of LE 453.42 Venous Embolism And Thrombosis Of Deep vessels of distal LE 453.8 Embolism and thrombosis of other specified veins 453.81 Acute venous embo & thromb sup veins upper ext 458.0 Orthostatic hypotension 464.30 Acute epiglottitis without mention of complication 464.4 Croup 466.11 Acute bronchiolitis due to respiratory syncytial virus 475 Peritonsillar abscess 491.21 Obstructive chronic bronchitis, with (acute) exace 493.01 Extrinsic asthma with status asthma 493.02 Extrinsic asthma, with (acute) exacerbation 493.11 Intrinsic asthma with status asthma 493.21 Chronic obstructive asthma with status 493.22 Chronic obstructive asthma, with (acute exacerbation) 493.91 Unspecified asthma, with status asthmaticus 493.92 Asthma, unspecified, with (acute) exacerbation 511.0 Pleurisy without mention of effusion or current tuberculosis 512.1 Iatrogenic pneumothroax 512.8 Other spontaneous pneumothorax 518.0 Pulmonary collapse 518.81 Acute respiratory failure 519.11 Acute bronchospasm 525.11 Loss of teeth due to trauma 528.3 Cellulitis and abscess of oral soft 535.30 Alcoholic gastritis without mention of hemorrhage 537.0 Acquired hypertrophic pyloric stenosis 540.9 Acute appendicitis without mention 541 Appendicitis; unqualified 550.10 Inguinal hernia with obstruction; without mention of gangrene 560.0 Intussusception 562.11 Diverticulitis of colon (without mention of hemorrhage 567.22 Peritoneal abscess 569.1 Rectal prolapse 574.10 Calculus of gallbladder with other cholecystitis 574.20 Calculus of gallbladder without mention of cholecystitis 575.0 Acute cholecystitis 575.10 Cholecystitis; unspecified without mention of calculus 578.0 Hematemesis 578.9 Unspecified; hemorrhage of gastrointestinal tract 590.10 Acute pyelonephritis without lesion of renal medullary necrosis 590.80 Unspecified pyelonephritis, not specified as acute or chronic 592.0 Calculus of kidney 592.1 Calculus of ureter 592.9 Unspecified urinary calculus 596.0 Bladder neck obstruction 607.3 Priapism 608.20 Torsion of testis, unspecified 608.23 Torsion of appendix testis 616.3 Abscess of Bartholin's gland 616.4 Other abscess of vulva 632 Missed abortion 633.00 Abdominal pregnancy without intrauterine implantation (abdominal pregnancy) 633.01 Abdominal pregnancy with intrauterine pregnancy BOTH 633.10 Tubal pregnancy without intrauterine pregnancy (UBAL ONLY) 633.90 Unspecified ectopic pregnancy without intrauterine pregnancy 634.10 Unspecified spontaneous abortion complicated by delayed or excessive hemorrage 634.11 Incomplete spontaneous abortion complicated by delayed or excessive hemorrhage 634.12 Complete spontaneous abortion complicated by delayed or excessive hemorrhage 634.70 Unspecified spontaneous abortion with other specified complications 634.72 Complete spontaneous abortion with other specified complications 634.81 Incomplete spontaneous abortion with unspecified complications 634.90 Unspecified spontaneous abortion without mention of complication 634.91 Incomplete spontaneous abortion without mention of complication 634.92 Complete spontaneous abortion without mention of complication 635.10 Unspecified legally induced abortion complicated by delayed or excessive hemorrage 635.11 Incomplete legally induced abortion complicated by delayed or excessive hemorrhage 635.12 Complete legally induced abortion complicated by delayed or excessive hemorrhage 635.71 Incomplete legally induced abortion with other specified complication 635.90 Unspecified legally induced abortion without mention of complication 635.91 Incomplete legally induced abortion without mention of complications 637.10 Abortion, unspecified as to complete complicated by delayed or excessive hemorrage 637.11 Legally unspecified abortion; incomplete; complicated by delayed or excessive hemorrhage 637.12 Legally unspecified abortion, complete, complicate 637.71 Legally unspecified abortion; incomplete; with other specified complications 637.90 Unspecified type of abortion; unspecified 637.91 Legally unspecified abortion, incomplete, without mention of complication 639.8 Other specified complication following abortion or ectopic and molar pregnancy 640.00 Threatened abortion; unspecified 640.03 Threatened abortion, antepartum 640.83 Other specified hemorrhage in early pregnancy 640.90 Unspecified hemorrhage in early pregnancy; unspecified episode of care 640.93 Unspecified hemorrhage in early pregnancy 641.13 Hemorrhage from placenta previa; antepartum 641.83 Other antepartum hemorrhage; antepartum assoc with trauma 641.93 Unspecified antepartum hemorrhage, 642.03 Benign essential hypertension antepartum 642.33 Transient hypertension of pregnancy, antepartum 642.43 Mild or unspecified pre-eclampsia, 642.44 Mild or unspecified pre-eclampsia; 642.54 Severe pre-eclampsia; previous post 642.73 Pre-eclampsia or eclampsia superimp 643.13 Hyperemesis gravidarum with metabolic disturbance 643.23 Late vomiting of pregnancy; antepartum condition/complication, Antepartum obstetric condition 644.03 Threatened premature labor, antepartum 644.1 Other threatened labor 644.13 Other threatened labor, antepartum 644.20 Early onset of delivery; unspecified 648.03 Maternal diabetes mellitus; antepartum 648.83 Abnormal maternal glucose tolerance, antepartum 649.53 Spotting complicating pregnancy; antepartum condit 655.73 Decreased fetal movements; affecting management of 657.03 Polyhydramnios, antepartum complication 658.03 Oligohydramnios, antepartum 658.13 Premature rupture of membranes in pregnancy, antepartum 661.93 Unspecified abnormality of labor; antepartum 674.84 Other complication of puerperium 681.01 Cellulitis and absess, Felon 681.9 Cellulitis and abscess of unspecified digit 682.0 Cellulitis and abscess of face 682.1 Cellulitis and abscess of neck 682.2 Cellulitis and abscess of trunk 682.3 Cellulitis and abscess of upper arm 682.4 Cellulitis and abscess of hand, excluding fingers and thumb 682.5 Cellulitis and abscess of buttock 682.6 Cellulitis and abscess of leg, except foot 682.7 Cellulitis and abscess of foot, except toes 682.8 Cellulitis and abscess of other specified place on head not face 682.9 Cellulitis and abscess of unspecified site 683 Acute lymphadenitis 685.0 Pilonidal cyst with abscess 728.86 Necrotizing fasciitis 728.88 Rhabdomyolysis 732.2 Nontraumatic slipped upper femoral epiphysis 736.1 Mallet finger 750.5 Congenital hypertrophic pyloric stenosis 767.0 Subdural and cerebral hemorrhage 770.81 Primary apnea of newborn 770.89 Other respiratory problems of newborn 780.01 Coma 780.2 Syncope and collapse 780.3 Convulsions 780.31 Febrile convulsions 780.32 Complex febrile convulsions 780.39 Other convulsions 782.5 Cyanosis 785.1 Palpitations 786.03 Apnea 786.07 Wheezing 786.1 Stridor 788.0 Renal colic 798.0 Sudden infant death syndrome 798.1 Instantaneous death 799.02 Hypoxemia 800.36 Closed fracture of vault of skull with other and unspec intracranial hem 801.00 Closed fracture of base of skull without mention 801.01 Closed fracture of base of skull 801.21 Closed fracture of base of skull 802.0 Nasal bones, closed fracture 802.20 Closed fracture of unspecified site 802.24 Closed fracture of unspecified part 802.25 Closed fracture of angle of jaw 802.27 Closed fracture of alveolar border 802.4 Malar and maxillary bones, closed fracture 802.6
Load more

Recommended publications
  • Temporomandibular Joint Dysfunction Corporate Medical Policy Policy
    Temporomandibular Joint Dysfunction Corporate Medical Policy File Name: Temporomandibular Joint Dysfunction File Code: UM.SURG.07 Origination: 06/2011 Last Review: 07/2019 Next Review: 07/2020 Effective Date: 10/01/2019 Description/Summary Temporomandibular joint (TMJ) dysfunction refers to a group of disorders characterized by pain in the TMJ and surrounding tissues. Initial conservative therapy is generally recommended; there are also a variety of nonsurgical and surgical treatment possibilities for patients whose symptoms persist. Policy Coding Information Click the links below for attachments, coding tables & instructions. Attachment I - CPT® Code Table & Instructions Attachment II - ICD-10-CM Diagnosis of TMJ When a service may be considered medically necessary • The following diagnostic procedures may be considered medically necessary in the diagnosis of temporomandibular joint (TMJ) dysfunction: - Diagnostic x-ray, tomograms, and arthrograms; - Computed tomography (CT) scan or magnetic resonance imaging (MRI) (in general, CT scans and MRIs are reserved for presurgical evaluations); - Cephalograms (x-rays of jaws and skull); - Pantograms (x-rays of maxilla and mandible). When a service is considered investigational • The following diagnostic procedures are considered investigational in the diagnosis of TMJ dysfunction: - Electromyography (EMG), including surface EMG; Page 1 of 17 Medical Policy Number: UM.SURG.07 - Kinesiography; - Thermography; - Neuromuscular junction testing; - Somatosensory testing; - Transcranial or lateral
    [Show full text]
  • CIHI - Canadian Institute for Health Information CEDIS - the Canadian Emergency Department Information System Committee
    CIHI - Canadian Institute for Health Information CEDIS - The Canadian Emergency Department Information System Committee ICIS - Institut canadien d'information sur la santé SIGDUC - le comité des systèmes d'informations de gestion des départements d'urgence canadiens Bernard Unger1, Marc Afilalo1, Jean François Boivin2, Michael Bullard3, Eric Grafstein4, Michael Schull5, Eddy Lang1, Antoinette Colacone1, Nathalie Soucy1, Xiaoqing Xue1, Eli Segal3 1 Emergency Multidisciplinary Research Unit, SMBD-Jewish General Hospital, McGill University, Montreal 2 Centre for Clinical Epidemiology and Community Studies, SMBD-Jewish General Hospital, McGill University, Montreal 3 University of Alberta Hospital, University of Alberta, Edmonton, Alberta 4 St. Paul's Hospital, Vancouver, University of British Columbia, Vancouver, British Columbia 5 Sunnybrook Health Sciences Centre and Institute for Clinical Evaluative Sciences, University of Toronto, Toronto, Ontario with/avec Canadian Institute for Health Information - Classifications & Terminologies and Clinical Administrative Databases (CAD) teams Institut canadien d'information sur la santé - les équipes de classifications & terminologies & des bases de données clinico-administratives (BDCA) Alberta Children's Hospital: Belanger F, Millar K BC Children's Hospital: Clarke M, Colbourne M, Haughton D, Hung G, Whitehouse S Canadian Pediatric Society Cape Breton Regional Hospital: Currie T Children's Hospital of Eastern Ontario: Farion K CH de l'Université de Montréal: Desaulniers P, Boulet M, Charbonneau L, Laurens JP, Jourdenais E CH de l'Université de Québec-Pavillon CHUL: Bernier D, Germain V, Guimont C, Nazair P, Turgeon R Colchester Regional Hospital: Howlett M Credit Valley Hospital, Mississauga: Humniski AM, Letovsky E, Scampoli N CSSS Gatineau: Folot MH, Forest G, Michaud MN, Pham Dinh M, Sibille P Foothills Medical Centre, Calgary: Wertzler B Greater Niagara General Hospital: Turineck D Grey Nuns Comm.
    [Show full text]
  • Workcover NSW 2012 Claims Estimation
    Minimum Weekly Compensation Estimate for Certain Injuries Extract from Workcover NSW Claims Estimation Manual - Dec 2012 Minimum Bodily Location And Injury Type Estimate GROUP 1: HEAD (includes cranium, eye, ear, mouth, nose and face) Fracture of skull (without brain injury) 6 weeks Fracture of jaw (without dislocation) 6 weeks Fracture-dislocation of jaw 12 weeks Concussion 1 week Serious head injuries (including closed/open head and brain injuries, severe facial Refer to Chapter J injuries involving face, nose and/or ear) Eye Major burn/thermal injury 26 weeks Moderate thermal or chemical burn 6 weeks Foreign body (corneal) and abrasions 2 weeks Foreign body (intraocular) 6 weeks Conjunctivitis/chemical irritation 1 week Contusions/bruising 1 week Retinal detachment 6 weeks Ear Perforated ear drum 2 weeks GROUP 2: NECK Whiplash associated disorder (WAD) without radicular pain 4 weeks Whiplash associated disorder (WAD) with radicular pain 12 weeks Contusion/bruising/sprains 4 weeks Fracture: to vertebral body 12 weeks to spinous or transverse process 6 weeks Fracture – dislocation 26 weeks Fracture with spinal cord injury Refer to Chapter J/Q GROUP 3: TRUNK (includes upper/lower back, chest, abdomen and pelvic region) Acute or recurrent back pain (non-radicular) 4 weeks Radicular back pain 12 weeks Fracture: of vertebral body 12 weeks of transverse or spinous process 6 weeks of sacrum 4 weeks of coccyx 4 weeks Contusion/bruising (upper/lower back) 4 weeks Chest/thorax: Closed rib fracture 4 weeks Fracture with complications (eg: pneumothorax)
    [Show full text]
  • Diagnostic Treatment Protocols Regulation Interpretative Guide
    Alberta Office of the Superintendent of Insurance Diagnostic Treatment Protocols Regulation Interpretative Guide Last updated: August 23, 2018 Alberta Treasury Board and Finance Superintendent of Insurance Financial Sector Regulation and Policy (FSRP) Room 402, Terrace Building 9515 - 107 Street Edmonton, Alberta, T5K 2C3 Phone 780-427-8322 • Fax 780-420-0752 For toll-free service in Alberta, call 310-0000, then enter the number. For more information, visit insurance.alberta.ca T able of Contents Table of Contents ........................................................................ 1 General Information .................................................................... 3 Introduction ..................................................................................................... 3 Scope of the Diagnosis and Treatment Protocols ......................................... 4 Definitions .................................................................................... 5 For the purposes of this Guide ....................................................................... 5 Claims and Billing ....................................................................... 6 Privacy Statement ....................................................................... 9 For Health Care Practitioners ......................................................................... 9 For More Information ..................................................................................... 9 Sprains and Strains ..................................................................
    [Show full text]
  • National Health Statistics Reports, Number 150, December 28, 2020
    National Health Statistics Reports Number 150 December 28, 2020 The 2020 International Classification of Diseases, 10th Revision, Clinical Modification Injury Diagnosis Framework for Categorizing Injuries by Body Region and Nature of Injury by Holly Hedegaard, M.D., M.S.P.H., National Center for Health Statistics; Renee L. Johnson, M.S.P.H., R.P.T., National Center for Injury Prevention and Control; Matthew F. Garnett, M.P.H., National Center for Health Statistics; and Karen E. Thomas, M.P.H., National Center for Injury Prevention and Control Abstract Introduction Background—Injury diagnosis frameworks, or matrices, based on the Injury diagnosis frameworks, such International Classification of Diseases (ICD) provide standardized categories for as the Barell matrix (1) and the Injury reporting injuries by body region and nature of injury. In 2016, the National Center for Mortality Diagnosis (IMD) matrix (2), Health Statistics (NCHS) and the National Center for Injury Prevention and Control provide standardized categories for (NCIPC) published a proposed injury diagnosis matrix for use with data coded using reporting injuries by body region and the ICD, 10th Revision, Clinical Modification (ICD–10–CM). At the time the proposed nature of injury. Nature of injury refers matrix was developed, ICD–10–CM coded data were not available to evaluate the to the type of anatomic or physiologic performance of the proposed matrix. As data became available, NCHS and NCIPC disruption (e.g., fractures, dislocations, received recommendations from clinicians and researchers to improve the consistency sprains, open wounds, burns, injuries and clinical applicability of categorization of codes within the matrix. This report to internal organs, or poisoning) that describes the modifications made to the 2016 proposed ICD–10–CM injury diagnosis occurred as a result of an injury event matrix and presents the final 2020 ICD–10–CM injury diagnosis matrix.
    [Show full text]
  • Temporomandibular Joint Disorder Treatment Product Applicability
    bmchp.org | 888-566-0008 wellsense.org | 877-957-1300 Medical Policy Temporomandibular Joint Disorder Treatment Policy Number: OCA 3.968 Version Number: 13 Version Effective Date: 01/01/17 + Product Applicability All Plan Products Well Sense Health Plan Boston Medical Center HealthNet Plan New Hampshire Medicaid MassHealth NH Health Protection Program Qualified Health Plans/ConnectorCare/Employer Choice Direct Senior Care Options ◊ Notes: + Disclaimer and audit information is located at the end of this document. ◊ The guidelines included in this Plan policy are applicable to members enrolled in Senior Care Options only if there are no criteria established for the specified service in a Centers for Medicare & Medicaid Services (CMS) national coverage determination (NCD) or local coverage determination (LCD) on the date of the prior authorization request. Review the member’s product-specific benefit documents at www.SeniorsGetMore.org to determine coverage guidelines for Senior Care Options. Policy Summary The Plan considers medical and/or surgical (non-dental) treatment of a temporomandibular joint (TMJ) disorder to be medically necessary ONLY when the disorder is caused by or results in a specific medical condition. Examples of specific medical conditions include jaw fractures and/or dislocations and degenerative arthritis. Prior authorization is required. It will be determined during the Plan’s prior authorization process if the treatment of a TMJ disorder is considered medically necessary for the requested indication (and must be related to a specific medical condition). See the Plan’s policy, Medically Necessary (policy number OCA 3.14), for the product- specific definitions of medically necessary treatment. Review the member’s applicable benefit Temporomandibular Joint Disorder Treatment + Plan refers to Boston Medical Center Health Plan, Inc.
    [Show full text]
  • Presents the Evaluation, Treatment and Management Of
    Presents The Evaluation, Treatment and Management of Temporomandibular Disorders, Craniofacial Pain And Orofacial Pain April 20, 2017 By Michael Karegeannes PT/MHSc/LAT/MTC/CFC/CCTT/CMTPT Jeff Verhagen PT/MBA/CMTPT Mike Verplancke DPT/CSCS/CMTPT Freedompt.com Treatingtmj.com Michael Karegeannes, PT, MHSc, LAT, MTC, CFC, CCTT, CMTPT, is the owner of Freedom Physical Therapy Services , 4 clinics in WI, since 1997 and a practicing physical therapist since 1989. His specialties in the field of physical therapy include: TMD, spine and pelvic dysfunctions, myofascial pain, and orthopedic therapies. Michael graduated from the University of Wisconsin-Madison in 1989 with a Bachelor’s of Science Degree in Physical Therapy. After he graduated, he received his athletic training license from the University of Wisconsin-Milwaukee, and later, Michael completed his manual therapy certification and Masters of Health Science from the University of St. Augustine in Florida. In 2005, Michael had the honor of being trained by Dr. Mariano Rocabado, (in conjunction with the University of St. Augustine) who is the leading national expert in the field of craniofacial therapies. Michael holds a Craniofacial Certification with the University of St. Augustine. In addition, Michael has attended an orofacial pain and TMD residency with the University of Minnesota Dental School. He is a member of the American Academy of Orofacial Pain (AAOP), a board member with the Physical Therapy Board of Craniofacial and Cervical Therapeutics (PTBCCT) and is one of the few physical therapists in the United States recognized as a certified cervical and temporomandibular therapist with the AAOP. In 2011, Michael received thorough and extensive training in the technique of intramuscular dry needling and is certified through Myopain Seminars, the premier post-graduate medical and physical therapy continuing education company in the United States with a focus on myofascial trigger points.
    [Show full text]
  • Temporomandibular Joint Disorders Policy Number: MP-016 Last Review Date: 02/21/2019 Effective Date: 04/01/2019 Policy
    Temporomandibular Joint Disorders Policy Number: MP-016 Last Review Date: 02/21/2019 Effective Date: 04/01/2019 Policy Evolent Health considers Temporomandibular Joint (TMJ) Disorders medically necessary for the following indications: Moderate to severe pain presented as TMJ pain, preauricular pain, referred ear pain, or masticatory muscle pain a) Disabling joint function characterized by: o Restricted range of jaw motion o Excessive range of jaw motion o Joint noises (clicking, popping, and crepitation) associated with pain o Abnormal masticatory function (e.g. painful chewing) b) Imaging evidence of joint derangement or disease Therapeutic Management: 1. Coverage for Nonsurgical Management: a) Medical visits b) Diagnostic x-rays/imaging studies (radiographs, panoramic radiographic imaging, cephalometic radiographic images, arthrogram, MRI and/or CT) c) Pharmacological treatment for pain – usually pain is relieved with over-the- counter non-steroidal anti-inflammatory drugs (NSAIDs) or other pain medications d) Arthrocentesis e) TMJ joint injections – intracapsular diagnostic and therapeutic injections or injections of anesthetic agents into the trigeminal nerve are limited to once per course of treatment Note: Documentation must indicate patient education related to stress reduction, dietary recommendations, jaw rest and modification of jaw habits. 2. Surgical treatment is indicated with at least two of the following: a) Earaches, headaches, masticatory or cervical myalgias refractory to medical treatment b) Difficulty chewing c) Restricted range of motion, manifested by any one of the following: i. Interincisal opening of less than 35 mm, or ii. Lateral excursive movement of less than 4 mm (side-to-side movement), or iii. Protrusive excursive movement of less than 4 mm (front-to-back motion), or iv.
    [Show full text]
  • Ministry of Health of Ukraine Ukrainian Medical Stomatolgical Academy Methodical Instructions for Independent Work of Students D
    Ministry of Health of Ukraine Ukrainian Medical Stomatolgical Academy Methodical Instructions for independent work of students during the training for the practical studies Academic discipline Surgical stomatology Module № 6 The topic of the stadies Arthritis, arthrosis, pain dysfunction syndrome of №6 temporomandibular joint. Ankylosis of TMJ. Plastic surgery of TMJ. Contractures and dislocations of the lower jaw. Diagnosis, surgical treatment and physiotherapy. Course V Faculty Foreign Students Training, Stomatological Poltava -2020 1. Relevance of the topic: Inflammatory and degenerative diseases of the TMJ belong to a rather common diseases are very difficult in its clinical course and difficult to treat, the frequency of which increases with age. Therefore, knowledge of the clinic, treatments and prevention of inflammatory and degenerative diseases of the TMJ is currently relevant in the study of this subject. 2. THE SPECIFIC AIMS: 2.1. To define what is arthritis, arthrosis, arthrito-arthrosis of the TMJ. 2.2. To analyze the etiology and pathogenesis arthritis, arthrosis, arthrito-arthrosis of the TMJ. 2.3. To suggest a plan of examination for patient with arthritis, arthrosis, arthrito- arthrosis of the TMJ. 2.4. To classify arthritis, arthrosis, arthrito-arthrosis of TMJ. 2.5. To list the main clinical features of acute TMJ arthritis. 2.6. To list the main clinical features of chronic TMJ arthritis. 2.7. To list the major clinical signs of osteoarthritis and TMJ arthritis. 2.8. To list the major clinical signs of TMJ osteoarthritis. 2.9. To appoint the treatment for patients with arthritis, arthrosis, arthrito-arthrosis of TMJ. 2.10. To analyze the data further diagnostic testing of patients with arthritis, arthrosis , arthritis, arthrosis of the TMJ.
    [Show full text]
  • Temporomandibular Joint Disorders Policy
    Manual: IU Health Plans Department: Utilization Management Policy # UMDET088.1 Effective Date: 12/19/2019 Supersedes Policy # UMDET088.0/or Last update or issue date: 05/01/2018 Page(s) Including attachments: 5 Medicare Advantage X Commercial Temporomandibular Joint Disorders Policy I. Purpose Indiana University Health Plans (IU Health Plans) considers clinical indications when making a medical necessity determination for Temporomandibular Joint Disorders. II. Scope All Utilization Management (UM) staff conducting physical and behavioral health UM review. III. Exceptions 1. The following services for TMJ disorders are ineligible or not covered for payment under this policy: A. Dental prostheses (stabilization splints) including the Therabite Jaw Motion Rehabilitation system or orthodontic treatment including irreversible occlusal therapy B. Physical Therapy C. Continuous Passive Motion (CPM) therapy D. Range of motion measurements E. Biofeedback F. Botulinum toxin (type A or Type B) G. Alloplastic joint implants H. Acupuncture I. Cognitive behavioral therapy J. Pulsed radiofrequency energy - Energex K. Electromyography L. Kinesiography M. Lateral skull X-rays N. Neuromuscular junction testing O. Nuclear medicine studies P. Somatosensory testing Q. Sonogram R. Transcranial X-rays S. Ultrasonic Doppler auscultation IV. Definitions None V. Policy Statements 1. IU Health Plans considers Temporomandibular Joint Disorders medically necessary for all of the following indications: A. Moderate to severe pain presented as TMJ pain, preauricular pain, referred ear pain, or masticatory muscle pain 1. Disabling joint function characterized by one or more of the following: a. Restricted range of jaw motion b. Excessive range of jaw motion c. Joint noises (clicking, popping, and crepitation) associated with pain d. Abnormal masticatory function (e.g.
    [Show full text]
  • Temporomandibular Joint Disorder
    Medical Policy MP 2.01.21 Temporomandibular Joint Disorder BCBSA Ref. Policy: 2.01.21 Related Policies Last Review: 02/21/2019 2.01.30 Biofeedback for Chronic Pain Effective Date: 02/21/2019 7.01.29 Percutaneous Electrical Nerve Stimulation and Section: Medicine Percutaneous Neuromodulation Therapy DISCLAIMER Our medical policies are designed for informational purposes only and are not an authorization, explanation of benefits or a contract. Receipt of benefits is subject to satisfaction of all terms and conditions of the coverage. Medical technology is constantly changing, and we reserve the right to review and update our policies periodically. POLICY DIAGNOSTIC PROCEDURES The following diagnostic procedures may be considered medically necessary in the diagnosis of temporomandibular joint disorder (TMJD): Diagnostic x-ray, tomograms, and arthrograms; Computed tomography (CT) scan or magnetic resonance imaging (MRI) (in general, CT scans and MRIs are reserved for presurgical evaluations); Cephalograms (x-rays of jaws and skull); Pantograms (x-rays of maxilla and mandible). (Cephalograms and pantograms should be reviewed on an individual basis.) The following diagnostic procedures are considered investigational in the diagnosis of TMJD: Electromyography (EMG), including surface EMG; Kinesiography; Thermography; Neuromuscular junction testing; Somatosensory testing; Transcranial or lateral skull x-rays; intraoral tracing or gnathic arch tracing (intended to demonstrate deviations in the positioning of the jaw that are associated with TMJD); Muscle testing; Standard dental radiographic procedures; MP 2.01.21 Temporomandibular Joint Disorder Range-of-motion measurements; Computerized mandibular scan (measures and records muscle activity related to movement and positioning of the mandible and is intended to detect deviations in occlusion and muscle spasms related to TMJD); Ultrasound imaging/sonogram; Arthroscopy of the temporomandibular joint (TMJ) for purely diagnostic purposes; Joint vibration analysis.
    [Show full text]
  • Temporomandibular Joint Disorder Treatment Product Applicability
    bmchp.org | 888-566-0008 wellsense.org | 877-957-1300 Medical Policy Temporomandibular Joint Disorder Treatment Policy Number: OCA 3.968 Version Number: 14 Version Effective Date: 12/01/17 + Product Applicability All Plan Products Well Sense Health Plan Boston Medical Center HealthNet Plan New Hampshire Medicaid MassHealth NH Health Protection Program Qualified Health Plans/ConnectorCare/Employer Choice Direct Senior Care Options ◊ Notes: + Disclaimer and audit information is located at the end of this document. ◊ The guidelines included in this Plan policy are applicable to members enrolled in Senior Care Options only if there are no criteria established for the specified service in a Centers for Medicare & Medicaid Services (CMS) national coverage determination (NCD) or local coverage determination (LCD) on the date of the prior authorization request. Review the member’s product-specific benefit documents at www.SeniorsGetMore.org to determine coverage guidelines for Senior Care Options. Policy Summary The Plan considers medical and/or surgical (non-dental) treatment of a temporomandibular joint (TMJ) disorder to be medically necessary ONLY when the disorder is caused by or results in a specific medical condition. Examples of specific medical conditions include jaw fractures and/or dislocations and degenerative arthritis. Prior authorization is required. It will be determined during the Plan’s prior authorization process if the treatment of a TMJ disorder is considered medically necessary for the requested indication (and must be related to a specific medical condition). See the Plan’s Medically Necessary medical policy (policy number OCA 3.14) for the Temporomandibular Joint Disorder Treatment + Plan refers to Boston Medical Center Health Plan, Inc.
    [Show full text]